Alembic Pharma receives US FDA final approval for Lacosamide tablets EP News Bureau Mar 22, 2022 Lacosamide tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
Glenmark Pharma receives ANDA approval for Lacosamide tablets EP News Bureau Mar 21, 2022 The company plans to launch the product immediately
